KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Edwards Lifesciences (EW) EBT Margin (2016 - 2025)

Historic EBT Margin for Edwards Lifesciences (EW) over the last 17 years, with Q3 2025 value amounting to 22.43%.

  • Edwards Lifesciences' EBT Margin fell 73100.0% to 22.43% in Q3 2025 from the same period last year, while for Sep 2025 it was 26.73%, marking a year-over-year decrease of 19400.0%. This contributed to the annual value of 28.46% for FY2024, which is 10700.0% up from last year.
  • According to the latest figures from Q3 2025, Edwards Lifesciences' EBT Margin is 22.43%, which was down 73100.0% from 26.12% recorded in Q2 2025.
  • Edwards Lifesciences' EBT Margin's 5-year high stood at 49.17% during Q4 2022, with a 5-year trough of 21.51% in Q2 2023.
  • For the 5-year period, Edwards Lifesciences' EBT Margin averaged around 30.72%, with its median value being 29.84% (2021).
  • As far as peak fluctuations go, Edwards Lifesciences' EBT Margin soared by 578300bps in 2021, and later plummeted by -201800bps in 2023.
  • Over the past 5 years, Edwards Lifesciences' EBT Margin (Quarter) stood at 28.3% in 2021, then surged by 74bps to 49.17% in 2022, then plummeted by -41bps to 29.0% in 2023, then decreased by -3bps to 28.15% in 2024, then fell by -20bps to 22.43% in 2025.
  • Its EBT Margin was 22.43% in Q3 2025, compared to 26.12% in Q2 2025 and 30.71% in Q1 2025.